Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...
The unprecedented increase in drug overdose deaths in the United States, long believed to be driven by access to legal and ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Washington — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...